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ABSTRACT
The objective was to determine if tobacco exposure is associated with year-round asthma
symptoms. We analyzed baseline data from a multistate survey of 896 pediatric patients with
asthma participating in a randomized controlled trial. Daytime symptoms, nocturnal symp-
toms, and limitations in activity because of asthma tend to increase during the winter sea-
son (p  0.05 for all comparisons, except spring to winter daytime symptoms). One hundred
forty of 896 (16%) children had year-round symptoms (i.e., active asthma symptoms dur-
ing every season). Using separate multivariate analyses, we found that having a parent who
smokes (odds ratio [OR]: 2.22; 95% confidence interval [CI]: 1.35, 3.64) or a member of the
household who smokes (OR: 1.94; 95% CI: 1.29, 2.93) was associated with a higher likeli-
hood of year-round symptoms, controlling for region of residence, insurance status, and use
of a daily controller medication. Asthma symptoms are more likely to increase in the win-
ter season. In anticipation of these patterns, clinicians should consider initiating controller
medication therapy or reinforcing asthma education prior to these time periods for those
patients at risk for seasonal exacerbations. Exposure to tobacco smoke is associated with
year-round asthma symptoms, highlighting the importance of health care providers identi-
fying and counseling about smoking cessation, especially for children with year-round asthma
symptoms. (Pediatr Asthma Immunol 2005; 18[4]:180–188.)
INTRODUCTION
SEASONAL VARIATION in asthma morbidity and health care utilization, such as emergency department vis-its or hospitalizations, is well-documented.1–5 Various factors, including viral infections, the onset of
cold weather and environmental allergens, may serve as “triggers” of asthma exacerbations contributing to
asthma severity. Understanding such variation in asthma symptoms is useful in helping anticipate, manage,
and control asthma symptoms.
Some patients exhibit continuous symptoms throughout the year. Indoor environmental factors, such as
tobacco smoke exposure, have been posited as contributing to asthma exacerbations. The persistence of
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year-round symptoms in these patients, however, can also be affected by other factors. For instance, insur-
ance type has been associated with decreased access to appropriate asthma care, leading to increased symp-
toms.6 In addition, patients who live in different parts of the country may be exposed to different climates
and seasonal allergy patterns. For example, so-called opportunistic weeds (e.g., ragweed) are stimulated by
higher CO2 concentrations found in warm, moist climates, leading to increased pollen production, which
has been shown to demonstrate geographic and temporal variation across geographic regions.7,8 Additional
influences that may have an impact on the frequency and duration of asthma symptoms include socioeco-
nomic level, peaks in respiratory infections, and regular exposure to triggers such as pet dander, among
other factors.9,10
The harmful effects of tobacco use have become increasingly prominent in medical literature as well as
in the media, particularly for children and adolescents. Although multiple influences are potential contrib-
utors to the likelihood of the appearance of asthma symptoms, the purpose of this study is to determine if
exposure to tobacco smoke is associated with more frequent symptoms and variations in seasonal patterns
in pediatric asthma, controlling for factors such as type of insurance, regional climate, and use of daily con-
troller medications.
MATERIALS AND METHODS
Using the baseline health status of a multistate sample of pediatric patients with asthma, we analyzed
parent responses to determine seasonal patterns of asthma symptoms in children. We have published pre-
vious analyses of these data to describe environmental control actions taken by parents and comparisons of
classifications of asthma severity using different measures.9,11 The University of Michigan Institutional Re-
view Board approved the study protocol, described below.
Subjects and respondents
The 896 pediatric patients in the sample were a random sample of children with symptomatic asthma
from the patient panels of pediatricians participating in a randomized controlled trial to evaluate the effect
of physician asthma education.
One hundred six physicians participated in the initial randomized controlled study. The pediatricians were
identified using yellow-page listings of pediatricians and membership lists from local professional societies
from 10 different regions including, Corpus Christi, Texas, Bakersfield, California; Nashville, Tennessee;
Jacksonville, Florida; Omaha, Nebraska; St. Paul, Minnesota; Kent County, Michigan; New Castle County,
Delaware; Columbus, Ohio; and Indianapolis, Indiana. A letter and brochure were sent to pediatricians invit-
ing them to participate in the study. They received continuing medical education credits, a certificate and
$50.00 honorarium for participating in the study.
Although the participating physicians were a convenience sample and not necessarily representative of
all practicing pediatricians, we surveyed a random sample of each physician’s asthma patients from lists
provided by each practice. Patients and their parents were blinded to physicians’ involvement in the inter-
vention. Physicians were blind to which patients were selected for the survey.
We developed a registry of 3368 patients from the lists of patients with asthma provided by each of the
participating physicians. From these 3368 patients, we randomly selected 2300 patients and were able to
contact the parents of 1933. Of the 1933 patients, 856 patients were found to not meet our inclusion crite-
ria, leaving 1077 potentially eligible patients. Criteria for inclusion in the study was as follows: a child must
be between 2 and 12 years of age, have no diseases with associated pulmonary complications (such as tu-
berculosis, sickle cell disease, or cystic fibrosis), and have active asthma (at least one hospitalization, emer-
gency department visit, or emergent visit [requiring the administration of epinephrine subcutaneously or a
bronchodilator by aerosol or metered-dose inhaler for nondiagnostic purposes] for asthma over the past 2
years). Children younger than 2 years of age were excluded, because the diagnosis of asthma can be diffi-
cult to establish before this age. Reasons for ineligibility included no diagnosis of asthma (n  140); no re-
cent health care utilization for asthma in the last 2 years (n  225); no visit with the study physician (n 
114); not between 2 and 12 years of age (n  153); parent works for the study physician (n  5); sibling
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of current study patient (n  3); other major disease (n  3); or a combination of the above (n  213). Be-
tween July 2001 and June 2002 we completed interviews with the parents of 896 of these 1077 potentially
eligible patients, a response rate of 83.1%.
Data collection
Trained interviewers contacted the households of randomly selected patients to administer the baseline
questionnaire by telephone. Prior to telephone contact, the pediatricians sent a letter explaining the study
to each of the households in their practice with potential study subjects. Parents of patients were provided
with the option of contacting the physician’s office to have their names removed from the list of potential
subjects.
Consent was obtained from the parent or legal guardian of each pediatric patient. The interview was con-
ducted in English. Interviewees were identified as the person who, “is usually responsible for the child’s
health-related care and takes him/her to the doctor.”
Using an open-ended format, respondents were asked to identify the number of days in a season (spec-
ified 3-month period) the child had daytime symptoms, nighttime symptoms, and the number of days of
limited daily activity because of asthma. Because recalling specifics of symptoms within a period as long
as a year without some sort of reference marker is all but impossible, researchers asked parents to discuss
symptoms by season. This allows for reporting of events that are associated with specific periods of the
year, which improves accuracy of reporting.12
To determine exposure to tobacco smoke, we asked if the parent or guardian smoked or if anyone in the
household smoked. We also collected demographic information including patient age, race, gender, asthma
severity, and insurance type, respondent age and gender, household income, and number of members of the
household.
Definition of variables
We defined a symptomatic season as any one season (3-month period) in which the child had greater
than 27 days of daytime symptoms or limited activity (i.e.,  2 days per week), or greater than 7 nights of
nighttime symptoms (i.e.,  2 nights per month), which was designed to mimic the National Heart, Lung,
and Blood Institute (NHLBI) cutoff for persistent asthma. Seasonal asthma was defined as the patient hav-
ing one symptomatic season. Year-round asthma was defined as a child having four symptomatic seasons.
Fall season was defined as September through November; winter as December to February; spring as March
to May; and summer as June to August.
Because we used a national sample of patients and because seasons vary across different regions of the
country,13 we controlled statistically for weather and climate, which can affect asthma symptoms.7 We hy-
pothesized that children who live in regions with low climate variability throughout the year would also be
less likely to have variability in asthma symptoms throughout the year. We used the International Energy
Conservation Code (IECC) climate zone system, which ranks regions based on temperature average and
range, as well as precipitation.14 We grouped regions into those with lower temperature variability (i.e.,
lower half of IECC rankings) versus those with high temperature variability (i.e., upper half of IECC rank-
ings). Based on this definition, those children living in Corpus Christi, Jacksonville, Bakersfield/Fresno,
and Nashville, were considered to live in regions of lower temperature variability.
Because younger children may be more likely to be predisposed to viral infections (e.g., bronchiolitis),
which can also trigger asthma symptoms or be similar to asthma symptoms, we controlled statistically for
the child’s age, as reported by the parent.15
Insurance type was also self-reported and classified as private insurance, Medicaid, state programs such
as the Children’s Health Insurance Program (CHIP), government non-Medicaid health insurance, other, and
self-pay. We hypothesized that type of insurance affects quality of and access to asthma care, and thus fre-
quency of symptoms.16
Use of a daily controller medication was defined as the parents’ report of daily use of the following types
of medications: inhaled corticosteroids, theophylline, leukotriene modifiers, cromolyn sodium, and combi-
nation therapies (e.g., long acting -agonists and daily inhaled corticosteroids).
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Analysis
We used univariate procedures to determine the measures of central tendency for days of each symptom
category, as well as univariate frequencies to determine the number of symptomatic seasons. We noted that
the number of days of symptoms was skewed. As a result, to compare differences in the number of days
of symptoms for each season, we used a Poisson linear regression model. Our dependent variable was the
number of days of symptoms for each season. We controlled for season of the year (winter, spring, sum-
mer, or fall), with winter as the reference season, because symptoms have been documented to increase
during this period.1,3,4
We used multivariate logistic regression to model the possible relationship between year-round symp-
toms and the following independent variables: insurance type (dichotomized into Medicaid and all other
types), patient age and gender, region of residence, use of daily controller medication, and parental (or
household) smoking status (n  896). We were concerned about the possibility of “clustering” of patients
receiving treatment by the same physician. The quality of physician care may affect the frequency of par-
ent-reported asthma symptoms. As a result, we included a general estimating equation (GEE) in the re-
gression analyses to allow for more robust estimates.17 Likewise, because the number of symptom days for
each season represented a repeated measure for each subject, we used GEE techniques to control for clus-
tering in all analyses. Statistical significance is defined as p  0.05. We used SAS 8.01 (SAS Institute,
Cary, NC) for all analyses.
RESULTS
Table 1 presents the characteristics of the patients, survey respondents and households. Patients had a
mean age of 7.2 years; 65% were male; and 61% reported use of a daily controller medication. There was
a smoker present in 216 (24%) of the households. The parent was the smoker in 112 (13%) of the house-
holds. Regarding location, 378 (42%) of the households were in a region with low temperature variability.
The most common type of insurance was described as “private” in 698 (78%) households. Of the re-
maining households, 123 (14%) had Medicaid; 37 (4%) had CHIP, 15 (2%) had government, non-Medic-
aid insurance, 14 (2%) were self-pay, and 9 (1%) were unknown or other.
Health care utilization in the previous year included an average of 0.13 (0.50) hospitalizations; 0.77
(1.96) emergency department visits and 4.4 (5.0) office visits for asthma. Patients were under the care
of their current physician for an average of 55 (38) months.
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TABLE 1. PATIENT AND RESPONDENT CHARACTERISTICS (n  896)
Male 584 (65%)
Mean Age in Years (std) 7.2 (2.9)
Mean Months Under physician’s care (std) 55 (38)





Respondent report of patient race (n  888)
White/Caucasian 643 (72%)
Black/African American 108 (12%)
Hispanic 93 (10%)
Asian/Pacific Islander 9 (1%)
Native American 9 (1%)
Other 26 (3%)
Residence in a region of decreased temperature variability 378 (42%)
std, standard deviation.
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Type and frequency of seasonal patterns
Table 2 provides the survey items and the mean, median and mode number of symptom days for each
season and symptom category. For daytime symptoms, nighttime symptoms, and limitations in activity,
winter was the season with the greatest mean number of days of symptoms (15.3; 12.0 and 9.0 days; re-
spectively). These differences were statistically significant (p  0.05); except for the comparison between
the mean number of daytime symptoms in winter compared to the spring season (15.3 days versus 14.2
days; p  0.09).
Table 3 displays frequency of seasons and number of symptomatic seasons. Based on our definition of
seasonal symptoms, we found that 165 (18%) children had seasonal asthma, with 109 (12%) having two
symptomatic seasons; 97 (11%) three symptomatic seasons; 140 (16%) four symptomatic seasons. The re-
maining 385 (43%) children did not have any symptomatic seasons.
Of these patients with any seasonal increases in symptoms, winter (December, January, and February)
was the most frequent problem season for 382 (46%) children. Of the patients with only one symptomatic
season, winter was also the most frequent problem season for 76 (46%) of 165 children.
Factors associated with year-round asthma symptoms
Based on our definition of year-round asthma, we found that 16% of the patients had such symptoms. Us-
ing multivariate logistic regression analyses (Table 4, model 1), controlling for preschool age and gender, we
found that parental smoking status (OR: 2.22; 95% CI: 1.35, 3.64), receipt of Medicaid insurance (OR: 2.07;
95% CI: 1.64, 4.16), residence in a region with decreased temperature variability (OR: 2.07; 95% CI: 1.41,
3.03), and receipt of a daily controller medication (OR: 3.35; 95% CI: 2.11, 5.32) was associated with a higher
likelihood of year-round symptoms. The results were similar (Table 4, model 2) when tobacco smoke exposure
was represented by any member of the household smoking (OR: 1.94; 95% CI: 1.29, 2.93).
DISCUSSION
In our sample of children with asthma, we found that asthma symptoms tend to increase during the win-
ter season (December to February). Furthermore, 140 of 896 (16%) children had active asthma symptoms
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TABLE 2. MEAN, MEDIAN, AND MODE NUMBER OF DAYS OF ASTHMA SYMPTOMS: BY SYMPTOM TYPE AND SEASON
Daytime symptoms Nighttime symptoms Limitation in activity
Mean (std) Median Mode Mean (std) Median Mode Mean (std) Median Mode
Spring (March–May) 14.2 (20.8) 6 0 10.6 (19.7)* 4 0 7.7 (17.6)* 2 0
Summer (June–August) 7.9 (15.3)* 3 0 6.6 (15.4)* 1 0 5.7 (16)* 0 0
Fall (September–November) 13.6 (19.3)* 6 0 10.3 (17.5)* 4 0 7.6 (16.6)* 2 0
Winter (December–February) 15.3 (20.3) 7 0 12.0 (19.5) 5 0 9.0 (18.1) 2 0
*p  0.05 compared to mean number of days during the winter season.
TABLE 3. NUMBER OF SEASONAL PEAKS
Number of children with persistent Number of children with persistent
Season symptoms during this season symptoms only during this season
Spring 319 (36%) 36 (4%)
Summer 119 (22%) 15 (2%)
Fall 334 (37%) 38 (4%)
Winter 382 (43%) 76 (8%)
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during every season (i.e., year-round asthma symptoms). Exposure to tobacco smoke, either through parental
smoking or the presence of household smoking was associated with year-round symptoms. Other factors
associated with an increased likelihood of year-round symptoms included use of a controller medication,
Medicaid insurance, and region of residence.
Our finding that asthma symptoms are likely to worsen in the winter season is consistent with recent re-
search. For example, the National Cooperative Inner-City Asthma Study (NCICAS) noted that inner-city
children with asthma had significant worsening of wheezing symptoms during the fall and winter months
with decreases in symptoms during the summer.3 The rise in symptoms is also accompanied by an increase
in hospitalizations and emergency department visits due to asthma during the fall and winter months.1,3,4
In our analyses, factors associated with the likelihood of year-round asthma symptoms included region
of residence. We used region of residence as a proxy for variation in temperature, as patients living in re-
gions with less variation in temperature may be less likely to have variation in asthma symptoms through-
out the year. Region may be a proxy for other factors. For example, the geographic areas we demarcated
as having decreased temperature variability also have very humid climates, which may be a marker for other
factors (i.e., possible year-round mold exposure).
Medicaid insurance was associated with year-round symptoms. This type of insurance may be a marker
for other factors associated with access to and or quality of asthma care.18–20 For example, some researchers
have suggested that asthma education, including provision of benchmarks of control by health care profes-
sionals, may not be adequate for patients with Medicaid insurance.21,22 A qualitative study noted that asthma
education was often inadequate or difficult for the parents of children with Medicaid insurance to under-
stand.20 In addition, children from families of low socioeconomic status—frequently those insured by Med-
icaid—may suffer from lack of regular, comprehensive health care, which can lead to poorly managed
asthma.23
Our results suggest that use of a controller medication is associated with year-round asthma symptoms.
With any cross-sectional study, causality cannot be attributed in any particular direction. However, for this
variable (use of a controller medication), it is likely that the year-round symptoms may lead to prescription
of a controller medication, as opposed to the use of a controller medication leading to year-round asthma
symptoms.
This is the first study to demonstrate an association between year-round asthma symptoms and tobacco
smoke exposure. Although tobacco smoke exposure has been associated with more frequent asthma exac-
erbations, increased asthma symptoms, and decreased pulmonary function, we are not aware of any study
that has linked tobacco smoke exposure to a specific pattern of chronic, year-round asthma symptoms.24,25
In contrast to our findings, the NCICAS study found no significant difference in wheezing patterns between
those who were exposed to environmental tobacco smoke and those who were not exposed.3 The differ-
ence in findings between our study and the NCICAS study may be due to the fact that our definition of
asthma symptoms included coughing or limitations in activity due to asthma, whereas their definition did
not incorporate these elements. Also, unlike the NCICAS study, the population in this study was chosen
from the practices of private pediatricians in medium-sized cities, versus children from inner-city clinic
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TABLE 4. LOGISTIC REGRESSION MODELS FOR INCREASED LIKELIHOOD OF YEAR-ROUND ASTHMA SYMPTOMS
Model 1 Model 2
Characteristic OR (95% CI) OR (95% CI)
Patient age (5 yrs of age versus 5 yrs) 1.27 (0.84, 1.91) 1.30 (0.86, 1.96)
Daily controller medication 3.35 (2.11, 5.32) 3.38 (2.13, 5.38)
Male gender 0.86 (0.58, 1.27) 0.86 (0.58, 1.28)
Medicaid insurance 2.61 (1.64, 4.16) 2.69 (1.70, 4.26)
Residence in region with decreased temperature variability 2.07 (1.41, 3.03) 2.10 (1.43, 3.08)
At least one parent is a smoker 2.22 (1.35, 3.64) —
At least one member of the household is a smoker — 1.94 (1.29, 2.93)
OR, odds ratio; CI, confidence interval.
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populations, who may not have a consistent primary care physician. In addition, instead of comparing dif-
ferences in groups by average rates by each month of the year, we collapsed symptom data into seasons
(3-month periods) and compared number of seasons affected.
Constant exposure to irritants may explain the association between living in a home with smokers and
year-round asthma symptoms. Second-hand smoke is harmful to all individuals, but is particularly delete-
rious for children with asthma. Parents who smoke may have a higher level of tolerance for a child’s symp-
toms or may be less sensitive to noticing them. For example, Crombie et al.26 found that children who live
in homes with high levels of parental smoking had fewer health care contacts than children whose parents
do not smoke. The authors hypothesized that there may be a lack of awareness of asthma symptoms in such
situations.
Limitations
There are a number of limitations to this study. First, the data are drawn from a random sample of pe-
diatric patients of physicians participating in a randomized controlled trial. Because physicians were not
randomly selected, data obtained from the patients in the sample may not be generalizable to other popu-
lations. Second, smoking status was based on respondent self-report, which may be affected by social de-
sirability issues. We did not confirm the smoking status of the respondent with other measures, such as
urine cotinine analysis. Moreover, we did not measure the actual degree of exposure, but the only presence
of smokers in the household. Third, the results of the study may vary depending on the definition of sea-
sonal peak. For example, a more conservative definition of seasonal peak (e.g., a requirement for greater
days or nights with symptoms) might lead to a slightly different interpretation of the findings, with fewer
numbers of patients included in the calculations. Fourth, because the inclusion criteria required that patients
have active asthma (defined as a visit to a hospital, emergency department, or physician’s office for ad-
ministration of epinephrine or bronchodilator), the findings may not be as generalizable to all children with
varying levels of asthma. Finally, from a methodological standpoint, parents were asked to report their chil-
dren’s asthma symptoms over the past year; asking respondents to cluster the symptoms by season likely
improved the accuracy of the reports, but multiple reports throughout the year should improve accuracy.12
Implications
There are several implications for clinicians. Similar to other studies, we found that daytime symptoms,
nocturnal symptoms, and limitations in activity because of asthma are more likely to increase in the win-
ter. In anticipation of these patterns, clinicians should consider initiating controller medications or rein-
forcing asthma education for those patients at risk for seasonal exacerbations prior to these time periods,
perhaps as early as August or September in anticipation of the increase in symptoms occurring as the weather
cools.
These results underscore the detrimental effect of tobacco smoke exposure for children with asthma. Al-
though environmental tobacco smoke is a common trigger for asthma exacerbations in children,27 pedia-
tricians only infrequently counsel parents who smoke to quit, and even more rarely suggest that others in
the household quit.28 These results highlight the importance of identifying smokers in the household and
counseling for smoking cessation, especially for those children with asthma who report year-round symp-
toms.
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